Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth
Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence
Summary
Breast cancer, a malignant neoplasm, is the second most common cancer
and the most common cancer in women worldwide, accounting for 16% of
all female cancers, making the disease exceedingly prevalent. The number
of women diagnosed with breast cancer has increased over the past few
decades, but the number of deaths has declined due to earlier diagnosis
and better treatment options.
Browse Detail Report With TOC @ http://www.hexareports.com/report/breast-cancer-therapeutics-in-major-developed-markets/details
Breast cancer treatment has been revolutionized in the past four
decades, especially with increasing usage of targeted therapies. The
marketed products landscape comprises a wide range of treatment options,
including hormonal therapies, chemotherapies, combination therapies,
and targeted therapies. Nevertheless, significant unmet need remains for
products that can improve overall survival rate, time to disease
progression, and overall response.
Reasons to buy
This report will enable you to –
- Understand the clinical context of breast cancer by considering symptoms, etiology, pathophysiology, epidemiology, diagnosis, and treatment options.
- Identify the therapeutic strategies, products, and companies that dominate the current marketed products landscape and recognize gaps and areas of unmet need.
- Identify key pipeline trends in molecule type, administration route, mechanism of action, and novelty.
- Consider market opportunities and potential risks by examining trends in breast cancer clinical trial size, duration, and failure rate by stage of development, molecule type, and mechanism of action.
- Recognize the late-stage pipeline molecules that have demonstrated strong therapeutic potential in breast cancer by examining clinical trial data and multi-scenario product forecast projections.
- Compare treatment usage patterns, annual therapy costs, and market growth projections for the US, Canada, the UK, France, Germany, Italy, Spain, and Japan.
- Discover trends in licensing and co-development deals concerning breast cancer products and identify the major strategic consolidations that have shaped the commercial landscape.
About Us:
Hexa Reports is a market research and consulting organization,
offering industry reports, custom research and consulting services to a
host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients
obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/
No comments:
Post a Comment